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The innate immune response of macrophages (M) to spores, the environmentally acquired form of Bacillus
anthracis, is poorly characterized. We therefore examined the early M cytokine response to B. anthracis
spores, before germination. M were exposed to bacilli and spores of Sterne strain 34F2 and its congenic
nongerminating mutant (gerH), and cytokine expression was measured by real-time PCR and an enzyme-
linked immunosorbent assay. The exosporium spore layer was retained (exo) or removed by sonication
(exo). Spores consistently induced a strong cytokine response, with the exo spores eliciting a two- to
threefold-higher response than exo spores. The threshold for interleukin-1 (IL-1) production by wild-type
M was significantly lower than that required for tumor necrosis factor alpha expression. Cytokine production
was largely dependent on MyD88, suggesting Toll-like receptor involvement; however, the expression of beta
interferon in MyD88/M suggests involvement of a MyD88-independent pathway. We conclude that (i) the
B. anthracis spore is not immunologically inert, (ii) the exosporium masks epitopes recognized by the M, (iii)
the M cytokine response to B. anthracis involves multiple pattern recognition receptors and signaling
pathways, and (iv) compared to other cytokines, IL-1 is expressed at a lower spore concentration.
Bacillus anthracis, the causative agent of anthrax, is a highly
virulent gram-positive, spore-forming bacterium that is typi-
cally acquired through exposure to spores from anthrax spore-
infected animals or animal products or atypically through in-
tentional exposure as a biological weapon (7, 13). Virulent
strains of B. anthracis carry two large plasmids, pXO1 and
pXO2, which carry the genes encoding anthrax toxin produc-
tion and capsule formation, respectively, each of which is crit-
ical to the pathogenesis of anthrax infection.
B. anthracis exists in the environment as dormant spores
capable of resisting adverse conditions. Upon uptake by mac-
rophages (M), B. anthracis spores, the form initially encoun-
tered by M, rapidly germinate, with the outgrowth of vege-
tative bacilli constituting the first stage of anthrax spore
infection (14). Spore germination enables the bacteria to ac-
tively proliferate, synthesize their virulence factors (lethal and
edema toxins, capsule), and disseminate within the host, lead-
ing to massive septicemia (7). Thus, the recognition and elim-
ination of B. anthracis by M (6, 7, 28, 29, 45, 46) represent
critical early events in anthrax pathogenesis.
Since a successful innate immune response to B. anthracis
might prevent the replication and dissemination of the vege-
tative form, we examined the M cytokine response to B.
anthracis spores. Little is known about the ability of B. anthra-
cis spores to induce M cytokine responses, which might be
expected to activate macrophagicidal activity, thereby lowering
the replication and dissemination of bacilli. To address this
question, we used two approaches. First, we used the germi-
nation-proficient B. anthracis Sterne strain 34F2 (pXO1
pXO2) and examined the spore M interaction at 1 h, prior
to the spore germination and cytokine production, by employ-
ing quantitative PCR to study cytokine gene expression. Sec-
ond, we measured cytokine protein responses by M by using
the congenic germination-deficient gerH (gerH-null) strain
spores (43, 44). The tri-cistronic gerHABC operon encodes ger-
minant sensors in the presence of M and M-conditioned
media and is required for endospore germination within the
M environment (43). Since the germination-deficient (gerH)
mutant does not form vegetative bacilli in M cultures, it is a
useful tool for dissecting the M response to the B. anthracis
spore in the absence of germination and allows us to distin-
guish the response elicited to the spore form of B. anthracis
that does not express toxins or capsule from that elicited to
the vegetative form.
A second goal of this study was to determine the role of the
exosporium (exo) in the innate immune response to B. anthra-
cis. The exosporium of B. anthracis is the outermost layer of
the spores and contains a major structural glycoprotein, Bacil-
lus collagen-like protein of anthracis (BclA) (35, 36, 40), as well
as many enzymes, such as arginase and superoxide dismutase,
whose functions in B. anthracis pathogenesis are beginning to
be elucidated (3, 33). We recently reported that the presence
of the exosporium may influence spore germination within the
M (3) and that Sterne 34F2 spores lacking an exosporium
(exo) are more easily killed than those in which the exospo-
* Corresponding author. Mailing address: Center for Vaccine Devel-
opment, Department of Medicine, University of Maryland, 685 W. Bal-
timore Street, HSF I-480, Baltimore, MD 21201. Phone: (410) 706-5328.
Fax: (410) 706-6205. E-mail: sbasu1@medicine.umaryland.edu.
† Present address: National Institute of Allergy and Infectious Dis-
eases, Bethesda, MD.
 Published ahead of print on 5 March 2007.
2351
 o
n
 February 24, 2014 by Cardiff Univ
http://iai.asm
.org/
D
ow
nloaded from
 
rium is retained (exo) (20). We hypothesized that one expla-
nation for the decreased B. anthracis killing that we observed
with spores retaining the exosporium is that this structure may
mask important structures on the spore that are normally re-
sponsible for the induction of a more robust proinflammatory
cytokine response. Alternatively, proteins on the exosporium
(35), such as arginase and superoxide dismutase (3, 33), may
subvert the formation of oxidative radicals or other bacteri-
cidal mechanisms in M.
Toll-like receptors (TLRs) are a family of pattern recogni-
tion receptors expressed on cells of the immune system whose
role in innate immunity is to recognize microbial pathogens.
M express a molecule encoded by the myeloid differentiation
primary response gene 88 (the MyD88 gene), which serves as
an adaptor molecule and mediates TLR signaling for all but
two TLR responses (TLR3 and TLR4) (2, 4, 11, 16, 41). A
previous study found that heat-killed vegetative bacilli induced
tumor necrosis factor alpha (TNF-) expression by M
through TLRs in a MyD88-dependent manner (15). Previous
studies have also reported the involvement of TLRs in the
response to B. anthracis toxins or heat-killed bacilli or in the
systemic response to B. anthracis spore challenge (15, 26), but
relatively little is known about the involvement of TLRs in the
M response to B. anthracis spores prior to germination. Con-
sequently, in this study we examined the early cytokine mRNA
response of MyD88-dependent and -independent pathways to
B. anthracis spores prior to their germination to the vegetative
form.
We find that while spores are not immunologically inert,
105 B. anthracis spores/ml are required to elicit the expres-
sion of TNF- and other cytokines by M; however, as few as
100 spores induced a robust interleukin-1 (IL-1) response
compared to the untreated control. Further, the exosporium
blunted spore-induced cytokine generation by M. Finally,
while we confirm the dependence on the MyD88 adaptor pro-
tein for many B. anthracis-induced cytokine responses, we also
find that B. anthracis spores activated a MyD88-independent
signaling pathway manifested by the induction of beta inter-
feron (IFN-).
MATERIALS AND METHODS
B. anthracis strains and spore preparation. B. anthracis Sterne 34F2 and the
gerH (the congenic gerH-null) strain constructed from Sterne 34F2 were pre-
pared as previously described (20). For each experiment, viable spore titer was
determined by dilution plating before and after heat killing (65°C for 30 min).
The vegetative forms of Sterne 34F2 and gerH B. anthracis were generated by
growing the spores in germinant-rich media (LB broth) that enabled the gerH
spores to germinate. Bacillus numbers were determined by dilution plating on
LB agar plates.
Sonication of spores. The exosporium was removed by disruption of the spores
with sonication as previously described (20). This treatment did not alter the
viability of the spore or its ability to grow in laboratory culture medium (20).
Preparation of murine peritoneal M and culture. Primary peritoneal M
were obtained from mice 4 days after intraperitoneal inoculation with 3 ml of 3%
thioglycolate as previously described (20). While M from C57/BL6 mice (Jack-
son Laboratory, Bar Harbor ME) were used for most studies, for selected
experiments we used MyD88/ mice on a C57/BL6 background (kindly pro-
vided by Stefanie Vogel, Baltimore, MD). In addition, C3H/HeJ (LPSd) and
C3H/HeN (LPSn) mice were obtained from Charles River Laboratory (Wilming-
ton, MA). M were cultured according to the method of Fortier et al. with some
minor modifications (12). Washed cell suspensions were adjusted to 1.5  106
M per ml in culture medium containing RPMI 1640 with heat-inactivated fetal
bovine serum (2%) and penicillin and streptomycin (100 U/ml) and incubated in
a 6- or 12-well flat-bottomed tissue culture plate (Nunc A/S, Roskilde, Denmark)
in 5% CO2 at 37°C overnight. Cells were washed two or three times on the day
of the experiment with sterile phosphate-buffered saline (Gibco, Invitrogen,
Grand Island, NY), infected with the spores at a requisite multiplicity of infec-
tion (MOI), and incubated in RPMI 1640 without fetal bovine serum or antibi-
otics at 37°C in 5% CO2 for 60 min. Cells were then washed and lysed to obtain
mRNA. The recombinant endotoxin-neutralizing protein (rENP) from Saccha-
romyces cerevisiae was obtained from Seikagaku America (Falmouth, MA), and
B. anthracis spores or lipopolysaccharide (LPS) was preincubated for 15 min with
the rENP as per the manufacturer’s instructions prior to being added to M
cultures.
Isolation of mRNA and real-time PCR. Total cellular RNA was extracted from
M as described elsewhere (22, 41) and reverse transcribed using AMV reverse
transcriptase (Promega) and poly-T priming as recommended by the manufac-
turer. The resulting cDNA was quantified by using real-time PCR using SYBR
green PCR master mix (Applied Biosystems) and an ABI Prism 7900HT cycler.
Intron-spanning primers for detection of IL-1, TNF-, IFN-, IL-6, MIP1-,
and hypoxanthine phosphoribosyltransferase (HPRT) mRNAs were designed
using the Primer Express 2.0 program (Applied Biosystems). Relative gene
FIG. 1. B. anthracis spores elicit an early cytokine mRNA response
in primary M. B. anthracis spores (filled bars) or heat-killed bacilli
(open bars) were added at different MOIs to a culture of primary M
(3  106) that were placed in serum-free RPMI 1640 for the duration
of the infection (1 h). The mRNA levels for IL-1 (A), TNF- (B), and
IFN- (C) were quantified. **, P  0.01; *, P  0.05.
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expression was calculated using the CT method, where CT (threshold cycle)
refers to the cycle number at which the PCR product for a particular gene is
detected by the light cycler. The housekeeping (HPRT) gene was used as an
internal control, and relative gene expression was normalized to HPRT gene
expression by the following formula: 1.8CTHPRT  CTgene. The data are averages for two
to five independent experiments, and the samples from each experiment were
analyzed in duplicate or triplicate more than two times. Statistical analysis was
performed by one-way analysis of variance with repeated measures, followed by
the use of Dunnet’s multiple-comparison or Tukey’s multiple-paired-comparison
test, with P values of 0.05 considered significant.
Measurement of cytokines. Cell culture supernatants were quantified at the
University of Maryland Cytokine Core Laboratory for cytokine levels by using a
standard two-antibody enzyme-linked immunosorbent assay (ELISA) with com-
mercial antibody pairs and recombinant standards (Pierce-Endogen, Boston,
MA) as previously described (18). The data were analyzed using a computer
program (SoftPro; Molecular Devices).
RESULTS
B. anthracis spores elicit a dose-dependent cytokine re-
sponse in primary M. In order to determine whether B.
anthracis spores induced a cytokine response in M, we em-
ployed two approaches to minimize the possibility that vege-
tative bacilli would confound interpretation of the data. Real-
time PCR allowed an evaluation of cytokine mRNA 1 h after
addition of spores to M. Second, we used the gerH mutant
of Sterne 34F2, which germinates poorly in the presence of M
(43, 44). We measured levels of IL-1, TNF-, IFN-,
RANTES, and IL-6 because of their importance in stimulating
different components of the immune response, such as phago-
cytes (TNF-, IL-1), B cells, and antibody formation (IL-6).
We also looked at message levels of IFN- and RANTES as an
indicator of the MyD88-independent pathway of activation of
M. We first measured IL-1, TNF-, and IFN- mRNA
levels at three different MOIs: 3  107 spores per 3  106 M
(MOI, 10:1), 3  106 spores per 3  106 M (MOI, 1:1), and
6  105 spores per 3  106 M (MOI, 0.2:1). These MOIs
ranged from higher values used in other studies (15, 26, 29) to
lower values (0.2:1) not reported previously, to our knowledge.
We find that compared to uninfected M, spores were able to
induce IL-1, TNF-, and IFN- mRNA in a dose-dependent
fashion, with detectable TNF- and IFN- mRNA expression
at MOIs of 0.2:1 and 1:1, respectively (Fig. 1). During the
1-hour incubation, we observed minimal germination of spores
in the serum-free medium. Nevertheless, to ensure that the
cytokine induction was not attributable to vegetative bacilli, we
compared the ability of the spores to induce cytokine mRNA
to that of heat-killed vegetative bacilli. As shown in Fig. 1, at
each MOI there was greater induction of cytokine mRNA by
the spores than by the bacilli. Since the bacilli have a tendency
to form chains, the number of bacilli added on the basis of
CFU may actually be an underestimate of the number of bacilli
added to the cultures.
To confirm the observation that the spore form of B. anthra-
cis induces a M cytokine response, we added gerH spores at
a single MOI of 0.2:1 and measured cytokine protein (Fig. 2).
Here, too, the spores induced significant cytokine responses.
Further, these were greater than the responses to heat-killed
FIG. 2. The spore form of gerH B. anthracis elicits a stronger cytokine protein response than the vegetative form in murine M. Primary
murine M were exposed to the heat-killed vegetative or the exo form of the gerH B. anthracis spores at an MOI of 0.2:1 in serum-free RPMI
1640. The M were viable after 24 h, when the supernatants were harvested and analyzed by ELISA for amounts of IL-1 (A), TNF- (B), IL-6
(C), and RANTES protein (D) made by the M. **, P  0.01.
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bacilli generated from gerH spores that were added to the
M cultures. These differences were greatest for IL-1,
TNF-, and RANTES and less pronounced for IL-6. Thus, the
results shown in Fig. 1 and 2 demonstrate that spores of the
Sterne strain induce cytokine responses in M and that these
responses are not due to vegetative bacilli that may have
emerged during germination.
Removal of the exosporium increases spore-induced cyto-
kine responses. In previous studies, we demonstrated that the
exosporium layer that surrounds the spore has an important
role in the initial interaction of the spore with the host M
(20). In addition to the structural protein BclA, the exospo-
rium contains at least 20 different enzymes which may play a
role in the pathogenesis of anthrax spore infection (33, 34). We
therefore studied whether the exosporium affected spore-in-
duced cytokine responses by M. Sonication of spores removes
the exosporium, as monitored by electron microscopy, but does
not alter its growth curve in laboratory medium (20). We noted
that for each cytokine examined (Fig. 3), removal of the exos-
porium resulted in a more robust cytokine mRNA expression
in M 1 hour after infection. This was also observed when the
gerH spores were used in place of Sterne. The exosporium
itself, however, did not induce any cytokine response (data not
shown). These data suggest either that the exosporium masks
structures on the spore cortex critical to cytokine induction or
that enzymes on the exosporium may alter expression of the
spore-induced cytokines.
Low concentrations of B. anthracis spores induce IL-1. We
observed a robust ratio of IL-1 expression (both mRNA and
protein) to B. anthracis spores at an MOI ratio of 6  106
spores to 6  106 M (1:1) (Fig. 1 and 2). Since initial contact
with spores will most likely be at considerably lower concen-
trations, we determined the threshold doses of B. anthracis
gerH required to produce detectable levels of IL-1 and an-
other proinflammatory cytokine, TNF-. At every dose of
spores examined, the levels of IL-1 generated were four- to
sixfold greater than that of TNF-. Moreover, at doses as low
as 102 spores/106 M, the IL-1 response was significantly
greater than that for the medium control, whereas at the same
dose, the TNF- production was not significantly higher than
that for the medium control (Fig. 4). The finding that IL-1
production was easily detectable at doses of B. anthracis spores
that may closely approximate an environmental exposure sug-
gests that this cytokine may play an early and important role in
the innate immune response to B. anthracis infections. The
relatively high threshold for TNF- induction is also consistent
with the hypothesis that at the levels of spores likely to be
encountered via inhalation, there is relatively little cytokine
generation; however, at levels of B. anthracis likely to be en-
countered in the later phases of anthrax spore infection,
TNF- and undoubtedly other cytokines may play an impor-
tant role.
Cytokine response in M is MyD88 dependent. Since
Hughes et al. reported that the TNF- response to vegetative
FIG. 3. Exosporium-deficient spores elicit a stronger cytokine message response than spores covered with exosporium. Primary murine M
were exposed to the exo or exo forms of the Sterne spores at an MOI of 0.2:1, and cytokine message levels were quantified 1 h after exposure
by real-time PCR. The exo spores induced a significantly higher response for IFN- (A), IL-1 (B), TNF- (C), and IL-6 (D). **, P 0.01; *, P
0.05.
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B. anthracis bacilli was MyD88 dependent (15), we assessed
whether the M response to B. anthracis spores was similarly
dependent on MyD88 (Fig. 5). In the absence of MyD88, there
was loss of B. anthracis spore-induced expression of all cyto-
kines (IL-1, TNF-, IL-6) except for IFN-. This was true for
exo and exo responses. The IFN- mRNA expression was
reduced but not entirely abrogated in MyD88/ M (Fig. 5).
This observation was consistent with the known induction of
IFN- by MyD88-independent signaling through the TRIF/
TRAM pathway (41).
The IFN- response is not due to contaminating LPS. The
B. anthracis spores consistently upregulated IFN- message
levels in M, and this response was partially dependent on
MyD88 (Fig. 5). It therefore could be suggested that the IFN-
message is being elicited in response to a TLR 4 agonist, such
as LPS, that may contaminate our spore preparations. In order
to rule out the possibility of endotoxin contamination, we pre-
incubated our spore preparations with and without the ENP
from the horseshoe crab (Limulus polyphemus) and quantified
cytokine mRNA levels in wild-type M. The up-regulation of
IFN- message levels in response to either Sterne or gerH
(data not shown) spores was unaltered in the presence of ENP,
whereas the response to LPS was significantly abrogated (Fig.
6A), confirming that the IFN- response to the B. anthracis
spores was not due to contaminating endotoxin in the spore
preparations. These results were further supported by the data
from the C3H/HeJ mice, which lack functional TLR4 re-
sponses (30). Despite the lack of a functional TLR4-mediated
signaling pathway, we still observed an IFN- mRNA response
to the B. anthracis spores (Fig. 6B). These data indicate that
the IFN- response to the B. anthracis spores is independent of
signaling through TLR4 and not due to an endotoxin contam-
ination. Thus, there appear to be multiple signaling pathways
required for cytokine responses to B. anthracis spores.
DISCUSSION
We find that upon contact with M, spores, the form of B.
anthracis acquired by the host from the environment, are able
to initiate both an mRNA and a protein response for all proin-
flammatory cytokines examined; however, the concentrations
of B. anthracis required for cytokine expression (104 B. an-
thracis spores) are likely to exceed environmental inhalational
exposures. Significantly, however, unlike for the other cyto-
kines, as few as 100 spores per 106 M were required to induce
IL-1. This suggests a potentially important role for IL-1 in
the innate immune response to B. anthracis. Further, the pres-
ence of the exosporium that surrounds the spore reduces the
ability of B. anthracis spores to induce the cytokines. Finally,
since B. anthracis induces the expression of IFN- in a MyD88-
independent manner, and since IL-1 and TNF- appear to be
induced differently, the cytokine response to B. anthracis
spores likely requires the involvement of multiple signaling
pathways.
The initial host response to inhaled B. anthracis spores may
limit the replication and dissemination of the vegetative form
that leads to the production of the lethal and edema toxins and
ultimately host death. Consequently, it is critical to differenti-
ate between the M responses to the spore and to the later
vegetative forms, particularly since the toxins expressed by
vegetative forms may compromise host defenses. For example,
in susceptible mice, B. anthracis infection causes the alteration
in function and/or death of the M, which may allow it to avoid
detection by the innate immune system (13). Largely due to its
inhibitory effect on mitogen-activated protein kinases, lethal
toxin (LT) induces apoptosis of susceptible M (1, 9, 25, 27,
32); however, lysis of M may also occur as a result of the
accumulation of large numbers of bacilli (6).
Most studies of the M cytokine responses to B. anthracis
have employed either the vegetative form (bacilli) or a mixture
of spores and bacilli, since in the time required to induce
cytokine protein, the spores rapidly germinate to the vegetative
form within the M environment. In order to circumvent this
problem, we have studied the M response to B. anthracis
spores by real-time PCR as early as 1 hour postexposure, when
few of the spores are germinating. More importantly, we also
examined the cytokine response to germination-deficient
(gerH) B. anthracis spores to ensure that the M response
was to the spores alone. This congenic mutant of Sterne 34F2
has a markedly delayed germination within M but otherwise
has growth characteristics in laboratory medium similar to
those of its parent strain (20). We find that M responses to B.
anthracis are stronger against the spore than the vegetative
form, which indicates that the M may have an early and
critical role in inducing protection against anthrax spore infec-
tion prior to its germination to the vegetative form. We need to
FIG. 4. IL-1 is expressed at lower concentrations of spores than
TNF-. Primary murine M plated at 1  106 cells/well were chal-
lenged overnight with increasing amounts of the gerH exo spores,
and the supernatants were assayed by ELISA for IL-1 (A) and TNF-
(B) production. **, P  0.01; *, P  0.05; n.s., not significant, in
comparison to medium control levels.
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interpret the higher response to spores than to bacilli by keep-
ing in mind that the vegetative form that we used was from the
Sterne strain, which had the toxins but lacked the capsule,
which is normally present in fully virulent B. anthracis. It is
possible that the encapsulated bacilli may induce a cytokine
response that is just as robust as or even stronger than that
induced by the spores at low MOIs.
Using the gerH strain, we previously reported that M are
unable to kill the spore form of B. anthracis but rather kill the
emerging vegetative form in an NO-dependent manner (33).
Since IL-1 expression is required for M NO formation (10,
23, 39), the expression of this cytokine by M after exposure to
relatively low concentrations of spores suggests that the IL-1
response is critical to host defenses against B. anthracis. Our
finding of IL-1 protein in supernatants of M culture with as
few as 100 spores could be attributable in part to the effect of
secondary mediators generated during the 24-hour culture;
however, no similar phenomenon was apparent for TNF-. We
recently observed with LPS treatment of M that the expres-
sion of pro-IL-1, the inactive precursor of IL-1, is MyD88
dependent; however, the processing of this inactive precursor
to its mature form by caspase-1 required an IFN--mediated
signaling pathway that was MyD88 independent (17). Similar
MyD88-dependent and -independent mechanisms may be re-
quired for B. anthracis-induced IL-1 as well. Thus, killing of
B. anthracis by M may involve the formation of an “inflam-
masome” complex that involves caspase-1, adaptor proteins,
and IFN--activated STAT1 (17, 19, 21, 24). Others have re-
ported that since LT or B. anthracis induces IL-1, the induc-
tion of this cytokine may be involved in the lethality of anthrax
infection or in apoptosis, respectively (31, 32). In that event, it
is argued, targeting IL-1 may be of therapeutic benefit. If,
however, IL-1 were important to host defenses against B.
anthracis at a stage of the pathogenesis of anthrax spore infec-
tion that precedes germination and LT formation, as our data
suggest, then neutralizing IL-1 may allow the organism to
gain a foothold within the host and promote dissemination.
A second objective of this study was to determine whether
the exosporium plays a role in evading the immune response.
The M response to the B. anthracis spores was more robust
when the exosporium was not present. Immediately below the
exosporium is a multilayer proteinaceous layer composed of a
complex mixture of spore coat proteins, many of unknown
functions (8). It is conceivable that among this array of con-
stituents are agonists capable of engaging host cell pattern
recognition receptors. Our data suggest that the exosporium
either masked immunogenic epitopes on the B. anthracis
spore, similar to the effect reported with some bacterial cap-
sular polysaccharides (5), or actively down-modulated the M
response via the activity of some protein on the exosporium.
M exposed to the exosporium alone did not produce any
cytokines or upregulate any cytokine genes (data not shown),
indicating that for the M, the exosporium is “inert.” Recent
studies, including our own, have shown that in addition to the
hair-like structural protein BclA, the exosporium contains over
20 proteins on its surface (34), including enzymes that either
FIG. 5. The M mRNA cytokine response is dependent on MyD88. Primary murine M from MyD88/ or wild-type (WT) control C57/BL6
mice were exposed to Sterne exo spores of B. anthracis at an MOI of 0.2:1 for 1 h, and their cytokine message levels for IFN- (A), IL-1 (B),
TNF- (C), and IL-6 (D) were determined by real-time PCR. **, P  0.01; *, P  0.05, for comparison to medium control levels.
2356 BASU ET AL. INFECT. IMMUN.
 o
n
 February 24, 2014 by Cardiff Univ
http://iai.asm
.org/
D
ow
nloaded from
 
can promote germination (e.g., superoxide dismutase) or can
actively interfere with the killing ability of M (e.g., arginase)
(33). As an example, both exo and exo spores induced
similar amounts of inducible nitric oxide synthase (iNOS) in
M; however, the exo B. anthracis spores generated less of
the microbicidal NO, most likely because of the competition of
the arginase on the exosporium for the iNOS substrate in the
medium, arginine (33). Thus, the B. anthracis exosporium may
be an important target for future therapeutic strategies for
modulation of the immune response to B. anthracis.
Our data suggest that the signaling pathways involved in the
cytokine response to B. anthracis are complex. The different
levels of B. anthracis spores required to express IL-1 and
TNF- indicate that the spore utilizes distinct receptor path-
ways for the induction of these cytokines. Our data also sup-
port published reports that TLRs have an important role in the
M response to B. anthracis (15, 26). These conclusions are
based in part on the loss of generation of some cytokines in
M obtained from MyD88/ mice (15). Yet the identity(ies)
of the TLR(s) that mediates these cytokine responses remains
elusive.
Of particular interest, we find that the IFN- response to B.
anthracis spores is retained in the absence of MyD88. These
results were not due to contaminating endotoxin that may
signal through TLR4 via the known MyD88-independent
TRIF/TRAM pathway, since the response is not abrogated in
the presence of ENP and since the IFN- response was ob-
served in C3H/HeJ mice that lack a functional TLR4 complex
(Fig. 6).
We also find that the M iNOS response to the spore, but
not LPS, is critically dependent on the ability of the M to
internalize the spore (33). This suggests that there may be
intracellular receptors, such as nucleofide-binding oligomeriza-
tion domain 1 or 2 or TLR3, TLR7, TLR8, or TLR9, that play
a role in early responses to the B. anthracis spore. These may
recognize epitopes that are usually hidden by the exosporium
and may become exposed when the spore germinates within
the M. Significantly, peptidoglycan derived from a non-toxin-
producing Bacillus strain induced IL-1 expression in RAW
264.7 cells, demonstrating that IL-1 can be induced by bacilli
independently of toxins (42). Alternatively, cytosolic DNA
from an invasive strain of Listeria monocytogenes as well as
bacterial RNA was recently found to activate a potent IFN-I
response (21, 24, 37, 38). This activation of IFN-I was TLR
independent, as we observed for B. anthracis in our studies,
and required IFN regulatory factor 3, which is required for
transcriptional activation of IFN-.
In conclusion, our data show that B. anthracis spores induce
the expression of cytokines by M. This cytokine expression
occurs as early as 1 hour after exposure to B. anthracis spores
and in a dose-dependent manner, with IL-1 expression oc-
curring at significantly lower spore concentrations than are
required for expression of other cytokines examined. Cytokine
induction by B. anthracis spores involves multiple signaling
pathways, including both MyD88-dependent and -independent
(e.g., IFN-) cascades. Further, given the difference in the
number of spores required for the induction of IL-1 and
TNF-, these cytokines are likely induced by distinct pathways.
Finally, while the exosporium itself does not induce the expres-
sion of cytokines, its removal enhances the cytokine response
to the spores. Thus, the early interactions between B. anthracis
spores and M, before germination and subsequent toxin and
capsule production, appear to be both complex and important
in the pathogenesis of anthrax infection. A better understand-
ing of these events will be required before optimal therapeutic
strategies can be implemented.
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